| With ILD (n = 5) | Without ILD (n = 34) | p valueb) |
---|---|---|---|
Age (years) | Â | Â | Â |
 Median (range) | 55 (38–63) | 55 (29–74) | NS |
eGFR (mL/min) | Â | Â | Â |
 Median (range) | 90 (60–95) | 79.5 (48–120) | NS |
Smoking history | Â | Â | Â |
 Yes | 0 | 4 |  |
 No | 5 | 30 | NS |
Stage | Â | Â | Â |
 I | 0 | 7 |  |
 IIA | 2 | 13 |  |
 IIB | 2 | 4 |  |
 IIIA | 1 | 6 |  |
 IIIB | 0 | 1 |  |
 IIIC | 0 | 3 | NS |
Estrogen receptora) | Â | Â | Â |
 Positive | 4 | 20 |  |
 Negative | 1 | 14 | NS |
Progesterone receptora) | Â | Â | Â |
 Positive | 3 | 12 |  |
 Negative | 2 | 22 | NS |
HER 2 status | Â | Â | Â |
 Positive | 0 | 15 |  |
 Negative | 5 | 19 | NS |
Menopausal status | Â | Â | Â |
 Premenopausal | 1 | 13 |  |
 Postmenopausal | 4 | 21 | NS |
dd regimen administered | Â | Â | Â |
 Yes | 5 | 13 |  |
 No | 0 | 21 | < .05 |